Products for Research Use Only
RegisterLogin

Bavunalimab

CAT: 0804-HY-P99354-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99354-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer[1].
CAS Number
2329669-78-3
Product Name Alternative
Anti-Human CTLA4xLAG3; XmAb-22841
UNSPSC
12352203
Target
LAG-3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bavunalimab.html
Purity
99.408
Solubility
H2O
Smiles
[Bavunalimab]
Molecular Weight
(125.327 kDa)
References & Citations
[1]Perez-Santos M, et, al. Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents. Expert Opin Drug Discov. 2022 Nov 24;1-15.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T76859Bavunalimab
GTR18337918Bavunalimab Antibody
ICH5203-5mgBavunalimab Biosimilar - Research Grade
B22069601-01Anti-Human CTLA4xLAG3 (Bavunalimab)
PX-TA1813-01Bavunalimab Biosimilar - Anti-LAG3; CTLA4 mAb - Research Grade

Popular Products